Home > Items where Subject is "B Substances > Hallucinogens / Psychedelics"

up arrow imageUp a level
Export as
Group by: Item Type | No Grouping
Number of items at this level: 58.

Article

Andrews, Christina M and Hall, Wayne and Humphreys, Keith and Marsden, John (2024) Crafting effective regulatory policies for psychedelics: what can be learned from the case of cannabis? Addiction , Early online .

Lake, Stephanie and Lucas, Philippe (2024) The Global Psychedelic Survey: consumer characteristics, patterns of use, and access in primarily anglophone regions around the world. International Journal of Drug Policy , 130 .

Khairinisa, Miski Aghnia and Alfaqeeh, Mohammed and Rafif, Syauqi Nawwar and Muljono, Fajar Oktavian and Colin, Michelle Natasha (2023) Cannabis and other substance misuse: implications and regulations. Toxics , 11 , (9) .

Ciucă Anghel, Daniela-Mădălina and Nițescu, Gabriela Viorela and Tiron, Andreea-Taisia and Guțu, Claudia Maria and Baconi, Daniela Luiza (2023) Understanding the mechanisms of action and effects of drugs of abuse. Molecules , 28 , (13) .

O'Neill, Derek and Condron, Ita and Kelleher, Cathy and Lyons, Suzi and Mongan, Deirdre and Millar, Sean (2023) Analysis of national drug and alcohol data by regional health area. Drugnet Ireland , Issue 84, Winter 2023, insert , pp. 14-22.

Urban, Marvin M and Stingl, Moritz R and Meinhardt, Marcus W (2023) Mini-review: The neurobiology of treating substance use disorders with classical psychedelics. Frontiers in Neuroscience , 17 .

Marseille, Elliot and Bertozzi, Stefano and Kahn, James G (2022) The economics of psychedelic-assisted therapies: a research agenda. Frontiers in Psychiatry , 13 .

Millar, Sean (2022) Not-fatal drug-related hospital admissions in Ireland, 2020. Drugnet Ireland , Issue 83, Winter 2022 , pp. 16-20.

Breeksema, Joost J and Kuin, Bouwe W and Kamphuis, Jeanine and van den Brink, Wim and Vermetten, Eric and Schoevers, Robert A (2022) Adverse events in clinical treatments with serotonergic psychedelics and MDMA: A mixed-methods systematic review. Journal of Psychopharmacology , 36 , (10) , pp. 1100-1117.

Kurtz, Joshua S and Patel, Neal A and Gendreau, Julian L and Yang, Chenyi and Brown, Nolan and Bui, Nick and Picton, Bryce and Harris, Mark and Hatter, Matthew and Beyer, Ryan and Sahyouni, Ronald and Diaz-Aguilar, Luis Daniel and Castellanos, Joel and Schuster, Nathaniel and Abraham, Mickey E (2022) The use of psychedelics in the treatment of medical conditions: an analysis of currently registered psychedelics studies in the American Drug Trial Registry. Cureus , 14 , (9) .

Glowacki, David R and Williams, Rhoslyn Roebuck and Wonnacott, Mark D and Maynard, Olivia M and Freire, Rachel and Pike, James E and Chatziapostolou, Mike (2022) Group VR experiences can produce ego attenuation and connectedness comparable to psychedelics. Scientific Reports , 12 .

Lowe, Henry and Toyang, Ngeh and Steele, Blair and Grant, Justin and Ali, Amza and Gordon, Lorenzo and Ngwa, Wilfred (2022) Psychedelics: alternative and potential therapeutic options for treating mood and anxiety disorders. Molecules , 27 , (8) , p. 2520.

Jones, Grant and Ricard, Jocelyn A and Lipson, Joshua and Nock, Matthew K (2022) Associations between classic psychedelics and opioid use disorder in a nationally-representative U.S. adult sample. Scientific Reports , 12 .

Kuc, Joanna and Kettner, Hannes and Rosas, Fernando and Erritzoe, David and Haijen, Eline and Kaelen, Mendel and Nutt, David and Carhart-Harris, Robin L (2022) Psychedelic experience dose-dependently modulated by cannabis: results of a prospective online survey. Psychopharmacology , 239 , pp. 1425-1440.

Uthaug, Malin Vedøy and Davis, Alan K and Haas, Trevor Forrest and Davis, Dawn and Dolan, Sean B and Lancelotta, Rafael and Timmermann, Christopher and Ramaekers, Johannes G (2022) The epidemiology of mescaline use: pattern of use, motivations for consumption, and perceived consequences, benefits, and acute and enduring subjective effects. Journal of Psychopharmacology , 36 , (3) , pp. 309-320.

Kelly, John R and Gillan, Claire M and Prenderville, Jack and Kelly, Clare and Harkin, Andrew and Clarke, Gerard and O'Keane, Veronica (2021) Psychedelic therapy's transdiagnostic effects: a research domain criteria (RDoC) perspective. Frontiers in Psychiatry , 12 , p. 800072.

Miceli McMillan, Ricardo (2021) Global bioethical challenges of medicalising psychedelics. Journal of Psychedelic Studies , 5 , (2) , pp. 57-64. (In Press)

Eleftheriou, Maria Eleni and Thomas, Emily (2021) Examining the potential synergistic effects between mindfulness training and psychedelic-assisted therapy. Frontiers in Psychiatry , 12 , p. 707057.

Kelly, John R and Crockett, Matthew T and Alexander, Lauren and Haran, Maeve and Baker, Annie and Burke, Lisa and Brennan, Christine and O'Keane, Veronica (2021) Psychedelic science in post-covid psychiatry. Irish Journal of Psychological Medicine , 38 , (2) , pp. 93-98.

Gandy, Sam and Forstmann, Matthias and Lester Carhart-Harris, Robin (2020) The potential synergistic effects between psychedelic administration and nature contact for the improvement of mental health. Health Psychology Open .

Murrie, Benjamin and Lappin, Julia and Large, Matthew and Sara, Grant (2020) Transition of substance-induced, brief, and atypical psychoses to schizophrenia: a systematic review and meta-analysis. Schizophrenia Bulletin , 46 , (3) , pp. 505-516.

Bienemann, Bheatrix and Ruschel, Nina Stamato and Campos, Maria Luiza and Negreiros, Marco Aurélio and Mograbi, Daniel C (2020) Self-reported negative outcomes of psilocybin users: a quantitative textual analysis. PLoS ONE , 15 , (2) .

Pike, Brigid (2016) Terminology and information on drugs. Drugnet Ireland , Issue 57, Spring 2016 , p. 13.

Ives, Richard (2006) Volatile substance abuse: a review of findings in ESPAD 2003. Drugs: Education, Prevention and Policy , 12 , (5) , pp. 441-449.

Report

UNODC Laboratory and Scientific Service. (2024) Current NPS threats volume VII. Vienna: United Nations Office on Drugs and Crime.

United Nations Office on Drugs and Crime. (2024) The challenge of new psychoactive substances - a technical update. Vienna: United Nations.

World Health Organization. (2024) Clinical descriptions and diagnostic requirements for ICD-11 mental, behavioural and neurodevelopmental disorders. Geneva: World Health Organization.

Health Research Board. Irish National Focal Point to the European Monitoring Centre for Drugs and Drug Addiction. (2024) Ireland: national report for 2023 - drug markets and crime. Dublin: Health Research Board.

RADAR. (2023) RADAR A to Z: a guide to common drug names in Scotland. Edinburgh: Public Health Scotland.

An Garda Siochana. (2023) An Garda Síochána annual report 2022. Dublin: An Garda Siochana.

United Nations Office on Drugs and Crime. (2023) Current NPS threats volume VI. Vienna: United Nations Office on Drugs and Crime.

Patrick, Megan E and Miech, Richard A and Johnston, Lloyd D and O’Malley, Patrick M (2023) Monitoring the future panel study annual report. National data on substance use among adults ages 19 to 60, 1976-2022. Ann Arbor, MI: University of Michigan Institute for Social Research.

RADAR. (2022) A guide to common drug names in Scotland. Edinburgh: Public Health Scotland.

Doyle, Anne and Sunday, Salome and Galvin, Brian and Mongan, Deirdre (2022) Alcohol and other drug use among children and young people in Ireland: prevalence, risk and protective factors, consequences, responses, and policies. Dublin: Health Research Board.

Patrick, Megan E and Schulenberg, John E and Miech, Richard A and Johnston, Lloyd D and O'Malley, Patrick M and Bachman, Jerald G (2022) Monitoring the Future Panel Study annual report: National data on substance use among adults ages 19 to 60, 1976-2021. Ann Arbor, MI: University of Michigan Institute for Social Research.

Winstock, Adam R and Timmerman, C and Davies, E and Maier, LJ and Zhuparris, A and Ferris, JA and Barratt, Monica J and Kuypers, KPC (2021) Global drug survey (GDS) 2020 psychedelics key findings report. London: Global Drug Survey.

An Garda Siochana. (2020) An Garda Síochána annual report 2019. Dublin: An Garda Siochana.

European Monitoring Centre for Drugs and Drug Addiction. (2020) European drug report 2020: trends and developments. Luxembourg: Publications Office of the European Union.

National Advisory Committee on Drugs and Alcohol, Northern Ireland. Department of Health. (2017) Prevalence of drug use and gambling in Ireland and drug use in Northern Ireland 2014/15: regional drug and alcohol task force (Ireland) and health and social care trust (Northern Ireland) results. Bulletin 2. Dublin: Department of Health.

United Nations Office on Drugs and Crime. (2016) Terminology and information on drugs. New York: United Nations.

Centre for Public Health, Liverpool John Moores University. (2011) A summary of the health harms of drugs. London: Department of Health & National Treatment Agency for Substance Misuse.

Health Service Executive South. O'Mahony Carey, Sinead (2008) A guide to substance misuse for medical professionals. Tipperary: Health Service Executive.

Reaper-Reynolds, Sheilagh and Williams, James and Wolfe, Esther and Keane, Rory (2005) Understanding substances and substance use: a handbook for teachers. Kildare: South Western Area Health Board.

Webpage

Adley, Mark and Jones, Guy and Linnell, Michael (2024) The drugs wheel. URL: http://thedrugswheel.com/?page=wheels

European Union Drugs Agency. (2024) Frequently asked questions (FAQ): therapeutic use of psychedelic substances. URL: https://www.euda.europa.eu/publications/frequently...

Center for Forensic Science Research & Education. (2024) Novel psychoactive substances (NPS) trend reports. URL: https://www.cfsre.org/nps-discovery/trend-reports

FactSheet

Substance Abuse and Mental Health Services Administration. (2020) Tips for teens: the truth about hallucinogens, sedatives and prescription stimulants. Rockville, MD: Substance Abuse and Mental Health Services Administration.

Be Smart. Be Safe.. (2019) Home truths. Are you aware of the drugs that are all around us? Dublin: Be Smart. Be Safe.

Dail Debates

[Oireachtas] Dail Eireann debate. Written answer 144 - Legislative programme [Hallucinogenic substances] [26827/06]. (05 Jul 2006)

Book

Shapiro, Harry (2010) The media guide to drugs: key facts and figures for journalists. London: Drugscope .

Conference or Workshop Item

Darke, Shane (2020) Deaths due to new psychoactive stimulants. In: 2020 NDARC Seminar Series, 27 February 2020.

Garcia-Romeu, Albert (2017) Psychedelics as change agents in addiction and mood disorders. In: Society for the Study of Addictions annual conference 2017, 10 November 2017, Newcastle Upon Tyne.

Thesis

McCarthy, Muireann (2017) Recreational drug use being normalised amongst the young people of Ireland. Other thesis, University College Cork.

Video

Hall, Wayne (2022) NDARC webinar series presentation. Implications of the revival of therapeutic research on psychedelic drugs. National Drug and Alcohol Research Centre.

Audio

Society for the Study of Addiction. Calder, Robert (2023) Addiction audio. Season 2, 2023. London: Society for the Study of Addiction.

Dataset

United Nations Office on Drugs and Crime. (2023) Drugs monitoring platform (DMP) [International].

News

[Irish Times] , McKenna, John Agony and Ecstasy: Psychedelics as the next big health remedy? (10 Jun 2018)

AFP. [thejournal.ie] Ireland is a major buyer of hallucinogens from Europe's darknet. (02 Dec 2017)

This list was generated on Mon Oct 7 04:35:31 2024 IST.